ANIP logo

ANI Pharmaceuticals (ANIP) Shareholders equity

annual shareholders equity:

$428.53M-$29.07M(-6.35%)
December 31, 2024

Summary

  • As of today (May 21, 2025), ANIP annual stockholders equity is $428.53 million, with the most recent change of -$29.07 million (-6.35%) on December 31, 2024.
  • During the last 3 years, ANIP annual shareholders equity has risen by +$69.79 million (+19.45%).
  • ANIP annual shareholders equity is now -6.35% below its all-time high of $457.60 million, reached on December 31, 2023.

Performance

ANIP Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPbalance sheet metrics

quarterly shareholders equity:

$443.47M+$14.94M(+3.49%)
March 31, 2025

Summary

  • As of today (May 21, 2025), ANIP quarterly stockholders equity is $443.47 million, with the most recent change of +$14.94 million (+3.49%) on March 31, 2025.
  • Over the past year, ANIP quarterly shareholders equity has dropped by -$33.34 million (-6.99%).
  • ANIP quarterly shareholders equity is now -7.73% below its all-time high of $480.61 million, reached on June 30, 2024.

Performance

ANIP quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

ANIP Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-6.3%-7.0%
3 y3 years+19.4%+28.1%
5 y5 years+101.4%+120.4%

ANIP Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-6.3%+26.6%-7.7%+31.7%
5 y5-year-6.3%+119.0%-7.7%+131.8%
alltimeall time-6.3%>+9999.0%-7.7%>+9999.0%

ANIP Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
$443.47M(+3.5%)
Dec 2024
$428.53M(-6.4%)
$428.53M(-0.5%)
Sep 2024
-
$430.80M(-10.4%)
Jun 2024
-
$480.61M(+0.8%)
Mar 2024
-
$476.81M(+4.2%)
Dec 2023
$457.60M(+35.2%)
$457.60M(+0.6%)
Sep 2023
-
$454.71M(+4.7%)
Jun 2023
-
$434.47M(+28.0%)
Mar 2023
-
$339.48M(+0.3%)
Dec 2022
$338.54M(-5.6%)
$338.54M(+0.6%)
Sep 2022
-
$336.68M(-0.1%)
Jun 2022
-
$336.96M(-2.6%)
Mar 2022
-
$346.09M(-3.5%)
Dec 2021
$358.74M(+83.3%)
$358.74M(+87.4%)
Sep 2021
-
$191.40M(-0.3%)
Jun 2021
-
$191.92M(-5.8%)
Mar 2021
-
$203.71M(+4.1%)
Dec 2020
$195.70M(-8.0%)
$195.70M(+0.3%)
Sep 2020
-
$195.10M(+2.0%)
Jun 2020
-
$191.34M(-4.9%)
Mar 2020
-
$201.17M(-5.5%)
Dec 2019
$212.79M(+7.9%)
$212.79M(-0.2%)
Sep 2019
-
$213.13M(+2.6%)
Jun 2019
-
$207.66M(+4.0%)
Mar 2019
-
$199.71M(+1.2%)
Dec 2018
$197.26M(+12.9%)
$197.26M(+2.5%)
Sep 2018
-
$192.47M(+4.0%)
Jun 2018
-
$185.11M(+3.0%)
Mar 2018
-
$179.64M(+2.8%)
Dec 2017
$174.76M(+3.0%)
$174.76M(-4.4%)
Sep 2017
-
$182.80M(+3.5%)
Jun 2017
-
$176.55M(+2.5%)
Mar 2017
-
$172.21M(+1.5%)
Dec 2016
$169.65M(+6.0%)
$169.65M(+0.5%)
Sep 2016
-
$168.83M(+3.1%)
Jun 2016
-
$163.78M(+2.2%)
Mar 2016
-
$160.18M(+0.1%)
Dec 2015
$160.08M(+14.5%)
$160.08M(+2.7%)
Sep 2015
-
$155.89M(+4.3%)
Jun 2015
-
$149.50M(+3.3%)
Mar 2015
-
$144.74M(+3.5%)
Dec 2014
$139.78M(+241.3%)
$139.78M(+40.5%)
Sep 2014
-
$99.49M(+8.6%)
Jun 2014
-
$91.59M(-0.5%)
Mar 2014
-
$92.09M(+124.8%)
Dec 2013
$40.96M(+45.4%)
$40.96M(+11.6%)
Sep 2013
-
$36.69M(+3.4%)
Jun 2013
-
$35.49M(+36.4%)
Mar 2013
-
$26.03M(-7.6%)
Dec 2012
$28.18M
$28.18M(-12.7%)
Sep 2012
-
$32.29M(+4.4%)
DateAnnualQuarterly
Jun 2012
-
$30.92M(-18.6%)
Mar 2012
-
$38.00M(+0.5%)
Dec 2011
$37.82M(+97.5%)
$37.82M(-14.3%)
Sep 2011
-
$44.15M(+282.9%)
Jun 2011
-
$11.53M(-55.9%)
Mar 2011
-
$26.14M(+36.5%)
Dec 2010
$19.15M(+21.0%)
$19.15M(+25.1%)
Sep 2010
-
$15.30M(-42.5%)
Jun 2010
-
$26.63M(+15.7%)
Mar 2010
-
$23.01M(+45.3%)
Dec 2009
$15.83M(+14.5%)
$15.83M(+41.6%)
Sep 2009
-
$11.18M(+92.4%)
Jun 2009
-
$5.81M(-42.5%)
Mar 2009
-
$10.11M(-26.9%)
Dec 2008
$13.83M(-53.5%)
$13.83M(-9.3%)
Sep 2008
-
$15.25M(-26.4%)
Jun 2008
-
$20.71M(-19.7%)
Mar 2008
-
$25.79M(-13.2%)
Dec 2007
$29.73M(+64.5%)
$29.73M(-4.7%)
Sep 2007
-
$31.18M(-4.2%)
Jun 2007
-
$32.54M(+95.8%)
Mar 2007
-
$16.62M(-8.0%)
Dec 2006
$18.07M(+165.0%)
$18.07M(+100.1%)
Sep 2006
-
$9.03M(+250.2%)
Jun 2006
-
$2.58M(-45.1%)
Mar 2006
-
$4.69M(-31.2%)
Dec 2005
$6.82M(-57.2%)
$6.82M(-25.7%)
Sep 2005
-
$9.18M(-16.1%)
Jun 2005
-
$10.94M(-18.3%)
Mar 2005
-
$13.40M(-15.9%)
Dec 2004
$15.92M(+83.3%)
$15.92M(-19.3%)
Sep 2004
-
$19.73M(-11.0%)
Jun 2004
-
$22.17M(+194.7%)
Mar 2004
-
$7.52M(-13.4%)
Dec 2003
$8.68M(+87.8%)
$8.68M(-14.8%)
Sep 2003
-
$10.20M(+405.0%)
Jun 2003
-
$2.02M(-40.2%)
Mar 2003
-
$3.38M(-26.9%)
Dec 2002
$4.62M(+14.1%)
$4.62M(-9.1%)
Sep 2002
-
$5.09M(+261.7%)
Jun 2002
-
$1.41M(-52.3%)
Mar 2002
-
$2.95M(-27.3%)
Dec 2001
$4.05M(+90.6%)
$4.05M(-25.8%)
Sep 2001
-
$5.46M(+27.9%)
Jun 2001
-
$4.27M(-11.8%)
Mar 2001
-
$4.84M(+127.8%)
Dec 2000
$2.13M(-61.0%)
$2.13M(-29.8%)
Sep 2000
-
$3.03M(-15.5%)
Jun 2000
-
$3.58M(-28.4%)
Mar 2000
-
$5.01M
Dec 1999
$5.45M(+107.1%)
-
Dec 1998
$2.63M
-

FAQ

  • What is ANI Pharmaceuticals annual stockholders equity?
  • What is the all time high annual shareholders equity for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals annual shareholders equity year-on-year change?
  • What is ANI Pharmaceuticals quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals quarterly shareholders equity year-on-year change?

What is ANI Pharmaceuticals annual stockholders equity?

The current annual shareholders equity of ANIP is $428.53M

What is the all time high annual shareholders equity for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high annual stockholders equity is $457.60M

What is ANI Pharmaceuticals annual shareholders equity year-on-year change?

Over the past year, ANIP annual stockholders equity has changed by -$29.07M (-6.35%)

What is ANI Pharmaceuticals quarterly stockholders equity?

The current quarterly shareholders equity of ANIP is $443.47M

What is the all time high quarterly shareholders equity for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high quarterly stockholders equity is $480.61M

What is ANI Pharmaceuticals quarterly shareholders equity year-on-year change?

Over the past year, ANIP quarterly stockholders equity has changed by -$33.34M (-6.99%)
On this page